UK's Alliance Pharma slumps on CEO exit, delay in FY results publication
08/05/2024 11:15
** Shares of Alliance Pharma Plc ALAPH.L fall as much as
23.3% to 24.55p, stock among top pct losers across London
** International healthcare group says its CEO of six years
Peter Butterfield to leave business; Nick Sedgwick appointed new
chief executive
** Separately, co postpones publication of its results for
year ended Dec. 31, 2023, set to be released on May 8; says
audit process remains ongoing
** Co was originally scheduled to publish FY results on
April 23 and had postponed the announcement, citing more time
required for the audit process
** Shares hit the lowest level since July 2012
** Stock down 21% as of 1005 GMT, pushing YTD losses to ~38%
(Reporting by Aby Jose Koilparambil in Bengaluru)
((abyjose.koilparambil@thomsonreuters.com))